39 /100
MEDIUM RISK
Score updated May 30, 2026

PHIO — Phio Pharmaceuticals Corp. Dilution Risk Tracker

Track PHIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PHIO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
29%
📉 Score Deterioration 40%
• Score rose 20 points recently (worsening)
🔄 Reverse Split 30%
• 50-day avg $1.19 approaching $1 threshold
🔔 Track PHIO — Get forecast alerts →

💹 Market Data

Market Cap$12.90M
Shares Outstanding11.62M
Float11.55M
Cash$17.03M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 90.3% shares (2025Q4 vs prior)
18 institutional holders · 365.3K shares
#1 GEODE CAPITAL MANAGEMENT, LLC 92.6K shares
#2 VANGUARD GROUP INC 87.6K shares
#3 Cetera Investment Advisers 42.5K shares
+ 15 more holders Sign up free to view →

📉 Short Interest

Short Interest331.6K
Days to Cover1.9
% of Float2.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track PHIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PHIO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for PHIO
📊 PHIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PHIO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.